176 related articles for article (PubMed ID: 2060627)
1. Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease.
Schnabel D; Schröder M; Sandhoff K
FEBS Lett; 1991 Jun; 284(1):57-9. PubMed ID: 2060627
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency.
Rafi MA; de Gala G; Zhang XL; Wenger DA
Somat Cell Mol Genet; 1993 Jan; 19(1):1-7. PubMed ID: 8460394
[TBL] [Abstract][Full Text] [Related]
3. Non-neuronopathic Gaucher disease due to saposin C deficiency.
Tylki-Szymańska A; Czartoryska B; Vanier MT; Poorthuis BJ; Groener JA; Ługowska A; Millat G; Vaccaro AM; Jurkiewicz E
Clin Genet; 2007 Dec; 72(6):538-42. PubMed ID: 17919309
[TBL] [Abstract][Full Text] [Related]
4. Detection of a point mutation in sphingolipid activator protein-1 mRNA in patients with a variant form of metachromatic leukodystrophy.
Rafi MA; Zhang XL; DeGala G; Wenger DA
Biochem Biophys Res Commun; 1990 Jan; 166(2):1017-23. PubMed ID: 2302219
[TBL] [Abstract][Full Text] [Related]
5. Sulfatide activator protein. Alternative splicing that generates three mRNAs and a newly found mutation responsible for a clinical disease.
Holtschmidt H; Sandhoff K; Kwon HY; Harzer K; Nakano T; Suzuki K
J Biol Chem; 1991 Apr; 266(12):7556-60. PubMed ID: 2019586
[TBL] [Abstract][Full Text] [Related]
6. Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting.
Vaccaro AM; Motta M; Tatti M; Scarpa S; Masuelli L; Bhat M; Vanier MT; Tylki-Szymanska A; Salvioli R
Hum Mol Genet; 2010 Aug; 19(15):2987-97. PubMed ID: 20484222
[TBL] [Abstract][Full Text] [Related]
7. Acid beta-glucosidase: enzymology and molecular biology of Gaucher disease.
Grabowski GA; Gatt S; Horowitz M
Crit Rev Biochem Mol Biol; 1990; 25(6):385-414. PubMed ID: 2127241
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is caused by a mutation in the initiation codon of their common gene.
Schnabel D; Schröder M; Fürst W; Klein A; Hurwitz R; Zenk T; Weber J; Harzer K; Paton BC; Poulos A
J Biol Chem; 1992 Feb; 267(5):3312-5. PubMed ID: 1371116
[TBL] [Abstract][Full Text] [Related]
9. Human sphingolipid activator protein-1 and sphingolipid activator protein-2 are encoded by the same gene.
Reiner O; Dagan O; Horowitz M
J Mol Neurosci; 1989; 1(4):225-33. PubMed ID: 2484333
[TBL] [Abstract][Full Text] [Related]
10. Analysis of a splice-site mutation in the sap-precursor gene of a patient with metachromatic leukodystrophy.
Henseler M; Klein A; Reber M; Vanier MT; Landrieu P; Sandhoff K
Am J Hum Genet; 1996 Jan; 58(1):65-74. PubMed ID: 8554069
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.
Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574
[TBL] [Abstract][Full Text] [Related]
12. A non-glycosylated and functionally deficient mutant (N215H) of the sphingolipid activator protein B (SAP-B) in a novel case of metachromatic leukodystrophy (MLD).
Wrobe D; Henseler M; Huettler S; Pascual Pascual SI; Chabas A; Sandhoff K
J Inherit Metab Dis; 2000 Feb; 23(1):63-76. PubMed ID: 10682309
[TBL] [Abstract][Full Text] [Related]
13. A rare form of Gaucher disease resulting from saposin C deficiency.
Kang L; Zhan X; Ye J; Han L; Qiu W; Gu X; Zhang H
Blood Cells Mol Dis; 2018 Feb; 68():60-65. PubMed ID: 28457694
[TBL] [Abstract][Full Text] [Related]
14. Mutations causing Gaucher disease.
Horowitz M; Zimran A
Hum Mutat; 1994; 3(1):1-11. PubMed ID: 8118460
[TBL] [Abstract][Full Text] [Related]
15. [Disorders of sphingolipid activator proteins].
Suzuki Y
Nihon Rinsho; 1995 Dec; 53(12):3025-7. PubMed ID: 8577053
[TBL] [Abstract][Full Text] [Related]
16. Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of ceramide in vivo.
Klein A; Henseler M; Klein C; Suzuki K; Harzer K; Sandhoff K
Biochem Biophys Res Commun; 1994 May; 200(3):1440-8. PubMed ID: 8185598
[TBL] [Abstract][Full Text] [Related]
17. Gaucher disease due to saposin C deficiency is an inherited lysosomal disease caused by rapidly degraded mutant proteins.
Motta M; Camerini S; Tatti M; Casella M; Torreri P; Crescenzi M; Tartaglia M; Salvioli R
Hum Mol Genet; 2014 Nov; 23(21):5814-26. PubMed ID: 24925315
[TBL] [Abstract][Full Text] [Related]
18. Nucleotide sequence of cloned cDNA for human sphingolipid activator protein 1 precursor.
Dewji NN; Wenger DA; O'Brien JS
Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8652-6. PubMed ID: 2825202
[TBL] [Abstract][Full Text] [Related]
19. Neuronopathic juvenile glucosylceramidosis due to sap-C deficiency: clinical course, neuropathology and brain lipid composition in this Gaucher disease variant.
Pàmpols T; Pineda M; Girós ML; Ferrer I; Cusi V; Chabás A; Sanmarti FX; Vanier MT; Christomanou H
Acta Neuropathol; 1999 Jan; 97(1):91-7. PubMed ID: 9930900
[TBL] [Abstract][Full Text] [Related]
20. Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses.
Harzer K; Paton BC; Poulos A; Kustermann-Kuhn B; Roggendorf W; Grisar T; Popp M
Eur J Pediatr; 1989 Oct; 149(1):31-9. PubMed ID: 2514102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
